A2 Biotherapeutics (Series C)

Funding Details
Awarder
Inbox
Date Award
May 19, 2025
Vertical
Biotechnology
Funding URL
View Funding Page

Company Info
Company Description
A2 Biotherapeutics is a clinical-stage biotech company developing first-in-class logic-gated cell therapies to address the high unmet need in cancers. A2 Bio invented the proprietary Tmod™ cell therapy platform to tackle the fundamental challenge in cancer treatment - the ability of cancer medicines to distinguish between tumor and normal cells.
Market
Cancer treatment
Location
Agoura Hills, California, USA
Coinvestors
The Column Group, Samsara BioCapital

Links
Back to Home Back to Biotechnology Deals View Funding Announcement